Virus excess mortality: Excess mortality is not a valid measur | Robin Monotti Cory Morningstar

Virus excess mortality: Excess mortality is not a valid measure when standard antibiotics easily treated the novel virus. What affects excess mortality is not the poison, but whether the cure is administered in time or not. Given that the cure is the same for all respiratory viruses, given that it is widely available, given that with SARSCov2 the natural progression from infection to death is very slow, many weeks if not many months, then what happened is this: a novel virus with equivalent IFR to flu yet different was circulating, antibiotics were generally administered in time, therefore this prevented any excess mortality, until they were not administered for a period, and midazolam and remdesivir were administered instead, and this increased excess mortality.

This is not difficult. But you need to include antibiotics in the thinking or you will always miss the most important factor: the cure.

https://twitter.com/robinmonotti/status/1711761601756364854